VIEVAN
ActiveSummary
VIEVAN has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €203,577 and a net result of €29,195. Equity is growing by ~19.8% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability76▲+2
Solvency67▲+6
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €15,000 at 30 days acceptable
Liquidity short (current ratio 0.96 against 0.57 in 2023; short-term debt: 13.9% and cash: 7.8% of total assets), and 58.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
52 d early
2024
48 d early
2023
113 d early
2022
55 d early
2021
95 d early
2020
26 d early
2019
87 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 68 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 6 June (4 of the last 5 filed years within 40 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€203,577▲ 16.7%
2023 · €174,381
Total assets
€487,304▲ 1.8%
2023 · €478,814
Net result
€29,195▲ 57.0%
2023 · €18,600
Working capital
-€2,796▲ 89.1%
2023 · -€25,756
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€51,239▲ 49.4%€63,237▲ 23.4%€38,461▼ 39.2%€38,944▲ 1.3%€57,140▲ 46.7%
Net result€31,448within the sector's middle half▲ 78.0%€40,834within the sector's middle half▲ 29.8%€19,524within the sector's middle half▼ 52.2%€18,600within the sector's middle half▼ 4.7%€29,195within the sector's middle half▲ 57.0%
Equity€95,424within the sector's middle half▲ 49.2%€136,258within the sector's middle half▲ 42.8%€155,782within the sector's middle half▲ 14.3%€174,381within the sector's middle half▲ 11.9%€203,577within the sector's middle half▲ 16.7%
Total assets€399,077within the sector's middle half▲ 3.0%€476,701within the sector's middle half▲ 19.5%€477,876within the sector's middle half▲ 0.2%€478,814within the sector's middle half▲ 0.2%€487,304within the sector's middle half▲ 1.8%
Debt€303,653▼ 6.1%€338,325▲ 11.4%€320,408▼ 5.3%€303,178▼ 5.4%€282,904▼ 6.7%
Working capital€9,403below the sector's middle half▲ 81.5%-€6,702below the sector's middle half-€23,524below the sector's middle half▼ 251%-€25,756below the sector's middle half▼ 9.5%-€2,796below the sector's middle half▲ 89.1%
Solvency23.9%below the sector's middle half▲ 7.4pp28.6%below the sector's middle half▲ 4.7pp32.6%below the sector's middle half▲ 4.0pp36.4%within the sector's middle half▲ 3.8pp41.8%within the sector's middle half▲ 5.4pp
Current ratio1.32below the sector's middle half▲ 0.150.84below the sector's middle half▼ 0.470.51below the sector's middle half▼ 0.340.57below the sector's middle half▲ 0.060.96below the sector's middle half▲ 0.39
Return on assets (ROA)7.9%within the sector's middle half▲ 3.3pp8.6%within the sector's middle half▲ 0.7pp4.1%below the sector's middle half▼ 4.5pp3.9%below the sector's middle half▼ 0.2pp6.0%below the sector's middle half▲ 2.1pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 47% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €487,304
Fixed assets
€422,293 ▼ 5.2%
Current assets
€65,012 ▲ 93.6%
Equity and liabilities €487,304
Equity
€203,577 ▲ 16.7%
Provisions
€824 ▼ 34.4%
Debt
€282,904 ▼ 6.7%
Debt's share of the balance-sheet total falls from 63.3% to 58.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€91,451▲
2023 · €71,847
Cash flow
€63,507▲
2023 · €51,503
Debt to equity
1.39▼
2023 · 1.74
ROE
14.3%▲
2023 · 10.7%
Interest coverage
7.10▲
2023 · 6.91
Debt ≤ 1 year
€67,807▲
2023 · €59,339
Debt > 1 year
€215,085▼
2023 · €243,839
Income taxes
€15,498▲
2023 · €10,383
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,811 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.3%
went bankrupt
3.2%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,811 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €11,500 | €0 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €14,841 | €18,335 | €30,160 | €32,903 | €34,312 | ▲ 4.3% |
| Other operating charges640/8 | - | €2,119 | €2,252 | €2,041 | €2,126 | ▲ 4.2% |
| Gross operating margin9900 | €67,983 | €83,691 | €70,872 | €73,888 | €93,578 | ▲ 26.6% |
| Operating profit (loss)9901 | €51,239 | €63,237 | €38,461 | €38,944 | €57,140 | ▲ 46.7% |
| Financial income75/76B | - | €6 | €200 | €5 | €0 | ▼ 99.4% |
| Recurring financial income75 | €200 | €6 | €200 | €5 | €0 | ▼ 99.4% |
| Financial charges65/66B | - | €4,081 | €8,606 | €10,397 | €12,878 | ▲ 23.9% |
| Recurring financial charges65 | €4,235 | €4,081 | €8,606 | €10,397 | €12,878 | ▲ 23.9% |
| Profit (loss) for the period before taxes9903 | €47,204 | €59,162 | €30,055 | €28,552 | €44,262 | ▲ 55.0% |
| Transfer from deferred taxes780 | - | €39 | €431 | €431 | €431 | = |
| Transfer to deferred taxes680 | - | €2,156 | €0 | - | - | - |
| Income taxes67/77 | €15,755 | €16,211 | €10,963 | €10,383 | €15,498 | ▲ 49.3% |
| Profit (loss) for the period9904 | €31,448 | €40,834 | €19,524 | €18,600 | €29,195 | ▲ 57.0% |
| Transfer from tax-exempt reserves789 | - | €117 | €1,294 | €1,294 | €1,294 | = |
| Transfer to tax-exempt reserves689 | - | €6,469 | €0 | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €31,448 | €34,482 | €20,817 | €19,893 | €30,489 | ▲ 53.3% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €399,077 | €476,701 | €477,876 | €478,814 | €487,304 | ▲ 1.8% |
| Fixed assets21/28 | €360,204 | €440,192 | €453,440 | €445,231 | €422,293 | ▼ 5.2% |
| Tangible fixed assets22/27 | €360,204 | €440,192 | €453,440 | €445,231 | €422,293 | ▼ 5.2% |
| Land and buildings22 | - | €181,448 | €189,433 | €191,411 | €189,264 | ▼ 1.1% |
| Furniture and vehicles24 | - | €68,512 | €54,428 | €40,345 | €26,261 | ▼ 34.9% |
| Other tangible fixed assets26 | - | €190,232 | €209,578 | €213,476 | €206,768 | ▼ 3.1% |
| Current assets29/58 | €38,873 | €36,509 | €24,436 | €33,583 | €65,012 | ▲ 93.6% |
| Amounts receivable within one year40/41 | €16,447 | €22,150 | €17,779 | €20,579 | €25,224 | ▲ 22.6% |
| Trade receivables40 | - | €22,150 | €17,779 | €20,579 | €25,224 | ▲ 22.6% |
| Cash at bank and in hand54/58 | €21,559 | €13,232 | €5,741 | €10,198 | €37,977 | ▲ 272% |
| Deferred charges and accrued income490/1 | - | €1,128 | €916 | €2,806 | €1,811 | ▼ 35.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €399,077 | €476,701 | €477,876 | €478,814 | €487,304 | ▲ 1.8% |
| Equity10/15 | €95,424 | €136,258 | €155,782 | €174,381 | €203,577 | ▲ 16.7% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €76,023 | €116,857 | €136,381 | €154,980 | €184,175 | ▲ 18.8% |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €0 | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €0 | - | - |
| Tax-exempt reserves132 | - | €6,352 | €5,058 | €3,764 | €2,471 | ▼ 34.4% |
| Distributable reserves133 | - | €108,645 | €129,462 | €151,216 | €181,705 | ▲ 20.2% |
| Profit (loss) carried forward14 | €801 | €801 | €801 | €801 | €801 | = |
| Provisions and deferred taxes16 | - | €2,117 | €1,686 | €1,255 | €824 | ▼ 34.4% |
| Deferred taxes168 | - | €2,117 | €1,686 | €1,255 | €824 | ▼ 34.4% |
| Amounts payable17/49 | €303,653 | €338,325 | €320,408 | €303,178 | €282,904 | ▼ 6.7% |
| Amounts payable after more than one year17 | €274,150 | €295,114 | €272,448 | €243,839 | €215,085 | ▼ 11.8% |
| Financial debts170/4 | - | €210,916 | €182,448 | €153,839 | €125,085 | ▼ 18.7% |
| Other amounts payable178/9 | - | €84,198 | €90,000 | €90,000 | €90,000 | = |
| Amounts payable within one year42/48 | €29,471 | €43,211 | €47,961 | €59,339 | €67,807 | ▲ 14.3% |
| Current portion of amounts payable after more than one year42 | - | €28,328 | €28,468 | €28,609 | €28,754 | ▲ 0.5% |
| Trade debts44 | €1,672 | €7,416 | €4,451 | €7,349 | €2,363 | ▼ 67.8% |
| Suppliers440/4 | - | €7,416 | €4,451 | €7,349 | €2,363 | ▼ 67.8% |
| Taxes, remuneration and social security45 | - | €7,467 | €2,674 | €383 | €5,498 | ▲ 1,334% |
| Taxes450/3 | - | €7,467 | €2,674 | €383 | €5,498 | ▲ 1,334% |
| Other amounts payable47/48 | - | - | €12,367 | €22,998 | €31,192 | ▲ 35.6% |
| Accrued charges and deferred income492/3 | - | - | - | - | €12 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €31,448 | €40,834 | €19,524 | €18,600 | €29,195 | ▲ 57.0% |
| + Depreciation and write-downs630 | €14,841 | €18,335 | €30,160 | €32,903 | €34,312 | ▲ 4.3% |
| Operating cash flow (approximation) | €46,290 | €59,169 | €49,684 | €51,503 | €63,507 | ▲ 23.3% |
| Investment in fixed assets (approximation) | - | -€98,323 | -€43,408 | -€24,694 | -€11,373 | ▲ 53.9% |
| Change in cash | - | -€8,328 | -€7,491 | €4,458 | €27,778 | ▲ 523% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
13-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €200,000Eq €203,577 ▲16.7%
7 profitable years in a row build equity to €203,577.
09-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
06-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €150,000Eq €155,782 ▲14.3%
5 profitable years in a row build equity to €155,782.
27-04
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Highest result since 2018net €40,834 ▲29.8%
Operating result €63,237, net result €40,834, both a record.
31-12
Financial
Equity above €100,000Eq €136,258 ▲42.8%
4 profitable years in a row build equity to €136,258.
05-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
05-05
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
26-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
22-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
17-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 17 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Houthulst · 1 establishment unit since 2012
Ground area
754 m²
Building footprint
229 m²
Parcel 32015A0871/00N000, Flanders. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
VIEVAN
since 20122.205.594.413
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 32015A0871/00N000 | Flanders | 754 m² | 1 · 229 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Jarno Van Laere
BE 0780.966.497
Lochristi · Eq €202,984
HAMARY MEDIC
BE 0667.977.434
Courcelles · Eq €202,918
ELIGLORA SOINS
BE 0761.362.205
Ganshoren · Eq €202,704
THUISVERPLEGING HERTECANT KIRSTEN
BE 0507.969.105
Zottegem · Eq €205,234
DELIGNE ELODIE
BE 0793.874.823
Binche · Eq €201,764
Of 5,986 companies in sector 86940 we hold annual accounts for 1,811. 1,370 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded23-12-2011
Fiscal year end31-12
Activities, NACEBEL 2025
86940Nursing and midwifery
86951Physiotherapy
96220Beauty care and other beauty treatments
E-invoicing
Reachable via Peppol
Peppol ID
0208:0842093325
Also
9925:BE0842093325
Registered
24-11-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.